Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

DARK SECRETS: 22 - The Real Truth

London borough to completely ban junk food adverts amid obesity crisis

The policy would ban adverts for unhealthy products linked to obesity and diabetes

Evening Standard

Weight-loss jabs could soon be among most commonly used NHS drugs, top doctor says

Patients may eventually access weight-loss jabs at pharmacies in a drive to ‘turn the tide’ on rising obesity, Professor Sir Stephen Powis says

The Independent UK

Weight loss jabs could be transformative, says outgoing NHS England official

An estimated 1.5 million people are taking weight loss jabs in the UK.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Thousands to benefit as weight loss drug Mounjaro approved for new use

Australia and the United States have both approved the drug for the treatment of sleep apnoea

The Independent UK

The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

The Conversation

People's mental health often improves after weight-loss surgery. A study pinpoints the real reason why.

Feeling less stigma — not losing weight — was linked to better mental health and eating behaviors after bariatric surgery.

LiveScience

Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought

Researchers from the Cleveland Clinic said discontinuation of the drugs comes with reduced weight loss

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Food additive titanium dioxide likely has more toxic effects than thought, study finds

Controversial additive may be in as many as 11,000 US products and could lead to diabetes and obesity

The Guardian - US

The slimming shot: What price are you willing to pay for a dream body?

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal approval for dual purposes.

Euronews

Wegovy use spikes among teens as doctors grapple with obesity crisis

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for young people with obesity grows among families and doctors.

The Independent UK

Before-And-After Photos Of Woman, 53, Go Viral After She Transforms Into Bodybuilding Champion

A 53-year-old from Brazil shocks social media with jaw-dropping transformation photos and inspirational messages to her thousands of fans

Bored Panda

Eli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?

Both companies have established a solid presence in the weight-loss drug market, but only one of them can lead.

Barchart

Obese patients denied knee and hip replacements to slash NHS costs

Former health minister James Bethell calls on the government to do more to tackle the obesity crisis and end ‘misery for millions’

The Independent UK

How Making GLP-1s Available Over the Counter Can Unlock Their Full Potential

Drugs like Ozempic might not only address obesity but also alcoholism, smoking, and drug addiction.

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

Plunged in Debt

‘1000-Lb. Sisters’ & More: What is the Obsession Behind Reality Shows Following the Morbidly Obese?

Reality television has long captivated audiences by providing glimpses into lives vastly different from our own. Among the myriad of reality TV genres, shows focusing on morbidly obese individuals, such as 1000-Lb. Sisters and My 600-Lb. Life, has garnered significant attention. These programs delve into the daily struggles, health challenges,…

International Business Times UK

New Study Reveals Ozempic and Weight-Loss Drugs May Reduce Risk of Obesity-Linked Cancers

A recent study reveals that weight-loss medications such as Ozempic may reduce the risk of obesity-related cancers, including colorectal and breast cancer. Experts emphasise the importance of further research to confirm these promising findings.

PetsRadar

Obesity in dogs: Vet’s guide to signs, risks, and treatment

How to spot the signs and reduce the risks of this serious but preventable condition

Evening Standard

Thousands tackle diabetes risk using NHS scheme of exercise and healthy eating

The Healthier You Programme aims to prevent or delay type 2 diabetes through personalised support.

Get all your
news in one place.

100's of premium titles.
One news app.

The National (Scotland)

Takeaways facing portion size limits under council pilot scheme in obesity clampdown

A COUNCIL could soon order takeaways and fast-food restaurants to cut down on the portion sizes of food they offer in an attempt to tackle obesity…

The Independent UK

Some Africans have seen a big belly as a sign of wealth. It’s killing them

The contrast highlights Kenya’s growing inequality and the popularity of fast and processed foods

LiveScience

Can weight loss drugs help you drink less alcohol?

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.

The Guardian - UK

WeightWatchers scraps business model to team up with anti-obesity drugs provider

Brand shifts away from dieting towards weight-loss injections after filing for bankruptcy in the US

The Guardian - UK

Half a billion young people will be obese or overweight by 2030, report finds

Health of adolescents worldwide has reached a ‘tipping point’, authors of Lancet commission analysis warn

The Conversation

Is this bad for my health? Kenyan study tests three types of warning labels on food

The Independent UK

Weight loss jabs sent through the post ‘could help 15 million people and boost economic growth’

Obesity costs society about £98 billion a year, the Tony Blair Institute for Global Change (TBI) says

1 … 21 22 23 24

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.